Search Results - "Epaminonda, P"

Refine Results
  1. 1

    Effects of chronic administration of PPAR-γ ligand rosiglitazone in Cushing's disease by AMBROSI, Bruno, DALL'ASTA, Chiara, BECK-PECCOZ, Paolo, CANNAVO, Salvatore, LIBE, Rossella, VIGO, Teresa, EPAMINTONDA, Paolo, CHIODINI, Iacopo, FERRERO, Stefano, TRIMARCHI, Francesco, AROSIO, Maura

    Published in European journal of endocrinology (01-08-2004)
    “…Rosiglitazone, a thiazolidinedione compound with peroxisome proliferator-activated receptor-gamma (PPAR-gamma)-binding affinity, is able to suppress…”
    Get full text
    Journal Article
  2. 2

    Circulating ghrelin levels in basal conditions and during glucose tolerance test in acromegalic patients by CAPPIELLO, Vincenzo, RONCHI, Cristina, MORPURGO, Paola S, EPAMINONDA, Paolo, AROSIO, Maura, BECK-PECCOZ, Paolo, SPADA, Anna

    Published in European journal of endocrinology (01-08-2002)
    “…Ghrelin exerts a wide range of metabolic functions. In contrast to the body of information accumulated on the role of ghrelin on energy balance, the possible…”
    Get full text
    Journal Article
  3. 3

    Effects of two different somatostatin analogs on glucose tolerance in acromegaly by RONCHI, C, EPAMINONDA, P, CAPPIELLO, V, BECK-PECCOZ, P, AROSIO, M

    Published in Journal of endocrinological investigation (01-06-2002)
    “…Impaired glucose tolerance is present in many acromegalic patients and treatment with somatostatin analogs has variable effects on glycemic control. The aim of…”
    Get full text
    Journal Article
  4. 4

    Ultrasound-guided laser thermal ablation for parathyroid adenomas: analysis of three cases with a three-year follow-up by Adda, G, Scillitani, A, Epaminonda, P, Di Lembo, S, Motta, F, Cecconi, P, Vecchi, G, Arosio, M, Chiodini, I

    Published in Hormone research (01-01-2006)
    “…In patients with primary hyperparathyroidism (pHPT) the therapeutical choice is surgery. In patients with high surgical and anesthetic risks, ultrasound-guided…”
    Get more information
    Journal Article
  5. 5

    Detection of small bowel tumors by videocapsule endoscopy in patients with acromegaly by Ronchi, C. L., Coletti, F., Fesce, E., Montefusco, L., Ogliari, C., Verrua, E., Epaminonda, P., Ferrante, E., Malchiodi, E., Morelli, V., Beck-Peccoz, P., Arosio, M.

    Published in Journal of endocrinological investigation (01-06-2009)
    “…The prevalence of colon polyposis and malignancies is increased in acromegalic patients as compared to the general population. An epidemiological study…”
    Get full text
    Journal Article
  6. 6

    Ghrelin administration affects circulating pituitary and gastro-entero-pancreatic hormones in acromegaly by Arosio, M, Ronchi, CL, Gebbia, C, Pizzinelli, S, Conte, D, Cappiello, V, Epaminonda, P, Cesana, BM, Beck-Peccoz, P, Peracchi, M

    Published in European journal of endocrinology (01-01-2004)
    “…OBJECTIVE: Ghrelin, a gut-brain peptide involved in the control of energy homeostasis, affects antero-pituitary and gastro-entero-pancreatic (GEP) hormone…”
    Get full text
    Journal Article
  7. 7

    Evaluation of insulin resistance in acromegalic patients before and after treatment with somatostatin analogues by RONCHI, C. L, ORSI, E, GIAVOLI, C, CAPPIELLO, V, EPAMINONDA, P, BECK-PECCOZ, P, AROSIO, M

    Published in Journal of endocrinological investigation (01-06-2003)
    “…Many studies have recently shown that simple computer-solved indices, based on fasting glucose and insulin levels, closely mirror the euglycemic clamp…”
    Get full text
    Journal Article
  8. 8

    Evaluation of cardiac structure by echoreflectivity analysis in acromegaly: effects of treatment by CIULLA, M. M, EPAMINONDA, P, AROSIO, M, PALIOTTI, R, BARELLI, M. V, RONCHI, C, CAPPIELLO, V, SARTORIO, A, BUONAMICI, V, MAGRINI, F, BECK-PECCOZ, P

    Published in European journal of endocrinology (01-08-2004)
    “…Cardiac echoreflectivity is a noninvasive tool for evaluating cardiac fibrosis. The present paper aimed to study the modifications of cardiac echoreflectivity…”
    Get full text
    Journal Article
  9. 9

    Increased glucose-dependent insulinotropic polypeptide (GIP) secretion in acromegaly by Peracchi, M, Porretti, S, Gebbia, C, Pagliari, C, Bucciarelli, P, Epaminonda, P, Manenti, S, Arosio, M

    Published in European journal of endocrinology (01-07-2001)
    “…Acromegaly is often associated with fasting and postprandial hyperinsulinemia, and the mechanisms involved are only partly understood. Hypersecretion of…”
    Get full text
    Journal Article
  10. 10

    Alterations of haemostatic and fibrinolytic markers in adult patients with growth hormone deficiency and with acromegaly by Sartorio, A, Cattaneo, M, Bucciarelli, P, Bottasso, B, Porretti, S, Epaminonda, P, Faglia, G, Arosio, M

    “…Alterations of coagulation and fibrinolytic systems might contribute to the increased cardiovascular and cerebrovascular mortality observed in patients with…”
    Get more information
    Journal Article
  11. 11

    Elevated circulating somatostatin levels in acromegaly by AROSIO, M, PORRETTI, S, EPAMINONDA, P, GIAVOLI, C, GEBBIA, C, PENATI, C, BECK-PECCOZ, P, PERACCHI, M

    Published in Journal of endocrinological investigation (01-06-2003)
    “…GH increases hypothalamic somatostatin (SS) synthesis and secretion but it is unknown if chronic GH excess, as found in acromegaly, may influence circulating…”
    Get full text
    Journal Article
  12. 12

    Therapy for the syndromes of GH excess by Arosio, M, Cannavò, S, Epaminonda, P, Ronchi, C, Chiodini, I, Adda, G

    “…This short review summarizes the results of treatments now available in Italy for the management of GH and IGF-I excess due to primary pituitary somatotroph…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Gamma-Knife Radiosurgery in Acromegaly: A 4-Year Follow-Up Study by Attanasio, Roberto, Epaminonda, Paolo, Motti, Enrico, Giugni, Enrico, Ventrella, Laura, Cozzi, Renato, Farabola, Mario, Loli, Paola, Beck-Peccoz, Paolo, Arosio, Maura

    “…Stereotactic radiosurgery by gamma-knife (GK) is an attractive therapeutic option after failure of microsurgical removal in patients with pituitary adenoma. In…”
    Get full text
    Journal Article
  15. 15

    Long-Term Evaluation of Postoperative Acromegalic Patients in Remission with Previous and Newly Proposed Criteria by Ronchi, Cristina L., Varca, Virginia, Giavoli, Claudia, Epaminonda, Paolo, Beck-Peccoz, Paolo, Spada, Anna, Arosio, Maura

    “…Criteria to define remission of acromegaly have changed over years. Since 2000, criteria for cure are normal IGF-I levels and a nadir GH after oral glucose…”
    Get full text
    Journal Article
  16. 16

    New therapeutic options for acromegaly by Arosio, M, Ronchi, C L, Epaminonda, P, di Lembo, S, Adda, G

    Published in Minerva endocrinologica (01-12-2004)
    “…Acromegaly is a slowly developing disfiguring disease characterized by chronic growth hormone (GH) and insulin-like growth factor-I (IGF-I) excess and caused…”
    Get more information
    Journal Article
  17. 17

    Hypothalamic-pituitary-adrenal activity in type 2 diabetes mellitus: role of autonomic imbalance by Chiodini, Iacopo, Di Lembo, Sergio, Morelli, Valentina, Epaminonda, Paolo, Coletti, Francesca, Masserini, Benedetta, Scillitani, Alfredo, Arosio, Maura, Adda, Guido

    Published in Metabolism, clinical and experimental (01-08-2006)
    “…Symptomatic diabetic neuropathy has been found to be associated with hypothalamus-pituitary-adrenal (HPA) axis hyperfunction, but no data are available about…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Efficacy of radiotherapy in normalizing serum IGF-I, acid-labile subunit (ALS) and IGFBP-3 levels in acromegaly by Epaminonda, Paolo, Porretti, Silvia, Cappiello, Vincenzo, Beck-Peccoz, Paolo, Faglia, Giovanni, Arosio, Maura

    Published in Clinical endocrinology (Oxford) (01-08-2001)
    “…OBJECTIVE Radiotherapy (RT) has been used for many years in order to complete the cure of unsuccessfully operated acromegalic patients. Several studies have…”
    Get full text
    Journal Article
  20. 20